26.11.2011. 17:15 |
nada za oboljele od carcinoma
|
Cancer_vaccine_Nov_2011 uz djelomični prijevod
A cancer vaccine you can live with
20 Nov 2011
Vaxil's groundbreaking therapeutic vaccine, developed in Israel, could keep about 90 percent of cancers from coming back.
Julian Levy, CEO of Vaxil BioTherapeutics
As the world's population lives longer than ever, if we don't succumb to heart disease, strokes or accidents, it is more likely that cancer will get us one way or another. Cancer is tough to fight, as the body learns how to outsmart medical approaches that often kill normal cells while targeting the malignant ones.
In a breakthrough development, the Israeli company Vaxil
BioTherapeutics has formulated a therapeutic cancer vaccine,
now in clinical trials at Hadassah University Medical Center in
Jerusalem.
If all goes well, the vaccine could be available about six years
down the road, to administer on a regular basis not only to help
treat cancer but in order to keep the disease from recurring.
Izraelska kompanijA Vaxil Biotherapeutics je stvorila terapeutsku vakcinu za carcinom, koja se sada klinički testira u Hadassah University Medical Center u Jeruzalemu. Ako sve bude u redu,
vakcina bi se mogla početi aplicirati u roku od šest godina, primjenjivati regularno ne samo kao pomoć u tretitanju karcinoma već i da sprečava da se bolest ponovi.
|
|
|
| |